Clinical services network- clinical trial planning and execution

Active Awarded Last action

Contract number
75A50123F33004
Awardee
Awarding agency
Obligated
$317,148,294

Award facts

Contract value 100% obligated
$317,148,294.00 Current and potential, with all options
Completion date 64% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Westlake, MD 20817, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 · Clinical trial planning and execution - covid next generation vaccine $0
Terminate for Convenience P00008 · EOI::EO: radical transparency about wasteful spending::EOI notification of termination for convenience (partial) $0
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Supplemental Agreement for work within scope P00004 · Clinical trial planning and execution - covid next generation vaccine $12,445,355
Supplemental Agreement for work within scope P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 · TRI-nexgen $0
Original award $304,702,939

About this award

The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a delivery order valued at $317.1 million to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business headquartered in Bethesda, Maryland. This contract supports clinical trial planning and execution for COVID next-generation vaccine development, with work to be performed in Westlake, Maryland, and an ultimate completion date of August 21, 2028. The contract utilizes a cost-plus fixed-fee pricing model with no set-aside designation, reflecting TRI's competitive capabilities in open federal procurement competitions. The award leverages TRI's extensive experience in providing comprehensive clinical research support services to federal health agencies.

TRI is well-positioned to execute this mission given its track record managing complex clinical trial programs across multiple national health institutes, including the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), and National Institute on Drug Abuse (NIDA). The company maintains several substantial Indefinite Delivery Vehicle contracts that enable rapid procurement of services, including a $545.4 million IDV with NIAID for comprehensive research support. TRI's core competencies—encompassing clinical trial planning and execution, regulatory support, data management, safety monitoring, protocol development, and quality assurance—directly align with the vaccine development and clinical testing requirements of this ASPR award.

Quick answers

Who was awarded contract 75A50123F33004?

75A50123F33004 was awarded to Technical Resources International, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 22, 2023.

How much is contract 75A50123F33004 worth?

The government has obligated $317,148,294 on 75A50123F33004.

Is contract 75A50123F33004 an order under another contract?

Yes. 75A50123F33004 is a delivery order under 75A50120D00018, an indefinite delivery contract.

Was contract 75A50123F33004 competed?

The extent of competition for 75A50123F33004 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award